Impact of dialysis modality on survival of new ESRD patients with congestive heart failure in the United States

Kidney International

Volumn 64, Issue 3, 2003, Pages 1071-1079

  Stack, Austin G ^a,b   Molony, Donald A ^a   Rahman, Noor S ^a   Dosekun, Akinsansoye ^a   Murthy, Bhamidipati ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Congestive heart failure; Hemodialysis; Peritoneal dialysis; Survival

Indexed keywords

ADULT; AGED; ANAMNESIS; ARTICLE; BLOOD VOLUME; CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; DIALYSIS; DISEASE EXACERBATION; EVIDENCE BASED MEDICINE; FEMALE; HEMODIALYSIS; HUMAN; INCIDENCE; INTERMETHOD COMPARISON; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICARE; MORTALITY; PERITONEAL DIALYSIS; PRIORITY JOURNAL; REGRESSION ANALYSIS; SAFETY; SURVIVAL; TREATMENT INDICATION; UNITED STATES;

EID: 0041429526     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2003.00165.x     Document Type: Article

References (37)

1. COLLINS AJ, HAO W, XIA H, et al: Mortality risks of peritoneal dialysis and hemodialysis. Am J Kidney Dis 34:1065-1074, 1999
2. GOKAL R, FIGUERAS M. OLLE A, et al: Outcomes in peritoneal dialysis and haemodialysis - A comparative assessment of survival and quality of life. Nephrol Dial Transplant 14(Suppl 6):24-30, 1999
3. TANNA MM, VONESH EF, KORBET SM: Patient survival among incident peritoneal dialysis and hemodialysis patients in an urban setting. Am J Kidney Dis 36:1175-1182, 2000
4. GOKAL R: Peritoneal dialysis in the 21st century: An analysis of current problems and future developments. J Am Soc Nephrol 13(Suppl):S104-S115, 2002
5. TAKEDA K, NAKAMOTO M, HIRAKATA H, et al: Disadvantage of long-term CAPD for preserving cardiac performance: an echocardiographic study. Am J Kidney Dis 32:482-487, 1998
6. ENIA G, MALLAMACI F, BENEDETTO FA, et al: Long-term CAPD patients are volume expanded and display more severe left ventricular hypertrophy than haemodialysis patients. Nephrol Dial Transplant 16:1459-1464, 2001
7. BLOEMBERGEN WE, PORT FK, MAUGER EA, WOLFE RA: A comparison of cause of death between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol 6:184-191, 1995
8. WU G: Cardiovascular deaths among CAPD patients. Petit Dial Bull 157:S40-S44, 1983
9. ROSTAND RG, GRETES JC, KIRK KA: Ischemic heart disease in patients with uremia undergoing maintenance hemodialysis. Kidney Int 16:600-612, 1979
10. GANESH SK, HULBERT-SHEARON T, EAGLE K, et al: Mortality differences by treatment modality among incident ESRD patients with and without coronary artery disease. J Am Soc Nephrol 14:415-424, 2003
11. RAJA RM, KRASNOFF SO, MOROS JG, et al: Repeated peritoneal dialysis in treatment of heart failure. JAMA 213:2268-2269, 1970
12. MCKINNIE JJ, BOURGEOIS RJ, HUSSERL FE: Long-term therapy for heart failure with continuous ambulatory peritoneal dialysis. Arch Intern Med 145:1128-1129, 1985
13. MOUSSON C, TANTER Y, CHALOPIN JM, et al: Treatment of refractory congestive cardiac insufficiency by continuous peritoneal dialysis. Long-term course (in French). Presse Med 17:1617-1620, 1988
14. TORMEY V, CONLON PJ, FARRELL J, et al: Long-term successful management of refractory congestive cardiac failure by intermittent ambulatory peritoneal ultrafiltration. QJM 89:681-683, 1996
15. ELHALEL-DRANITZKI M, RUBINGER D, MOSCOVICI A, et al: CAPD to improve quality of life in patients with refractory heart failure. Nephrol Dial Transplant 13:3041-3042, 1998
16. U.S RENAL DATA SYSTEM: Patient characteristics at the start of ESRD: Data from the HCFA Medical Evidence Form. Am J Kidney Dis 34:S63-S73, 1999
17. LEVEY AS, BOSCH JP, BREYER LEWIS J, et al, FOR THE MDRD STUDY GROUP: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med 130:461-470, 1999
18. U.S. RENAL DATA SYSTEM: USRDS 2002 Annual Data Report, in Atlas of End Stage Renal Disease in the United States, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2002
19. STACK AG, BLOEMBERGEN WE: A cross-sectional study of the prevalence and clinical correlates of congestive heart failure among incident U.S. dialysis patients. Am J Kidney Dis 38:992-1000, 2001
20. STACK AG, BLOEMBERGEN WE: Prevalence and clinical correlates of coronary disease among incident U.S. dialysis patients: A cross-sectional study. J Am Soc Nephrol 12:1516-1523, 2001
21. AMANN K, MANDELBAUM A, SCHARZ U, RITZ E: Hypertension and left ventricular hypertrophy in the CAPD patient. Kidney Int 50 (Suppl 56):S37-S40, 1996
22. WANG T, HEIMBUGER O, WANIEWSKI J, et al: Increased peritoneal permeability is associated with decreased fluid and small-solute removal and higher mortality in CAPD patients. Nephrol Dial Transplant 13:1242-1249, 1998
23. Rocco MV, FRANKENFIELD DL, PROWANT B, et al: Centers for Medicare & Medicaid Services Peritoneal Dialysis Core Indicators Study Group. Risk factors for early mortality in U.S. peritoneal dialysis patients: Impact of residual renal function. Perit Dial Internat 22:371-379, 2002
24. ATES K, NERGIZOGLU G, KEVEN K, et al: Effect of fluid and sodium removal on mortality in peritoneal dialysis patients. Kidney Int 60:767-776, 2001
25. MENON MK, NAIMARK DM, BARGMAN JM, et al: Long-term blood pressure control in a cohort of peritoneal dialysis patients and its association with residual renal function. Nephrol Dial Transplant 16:2207-2213, 2001
26. JANSEN MA, HART AA, KOREVAAR JC, et al: NECOSAD Study Group. Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int 62:1046-1053, 2002
27. WOLFE RA: Observational studies are just as effective as randomized clinical trials. Blood Purif 18:323-326, 2000
28. GREENE T: Are observational studies "just as effective" as randomized clinical trials? Blood Purif 18:317-322, 2000
29. WOLFE R, PORT F, HAWTHORNE V, et al: A comparison of survival among dialytic therapies of choice: In-center hemodialysis versus continuous ambulatory peritoneal dialysis at home. Am J Kidney Dis 15:433-440, 1990
30. BLOEMBERGEN W, PORT F, MAUGER E, et al: A comparison of mortality between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol 6:177-183, 1995
31. MAIORCA R, CANCARINI GC, ZUBANI R, et al: CAPD viability: A long-term comparison with hemodialysis. Perit Dial Int 16:276-287, 1996
32. FENTON S, SCHAUBEL D, DESMEULES M, et al: Hemodialysis versus peritoneal dialysis: A comparison of adjusted mortality rates. Am J Kidney Dis 30:334-342, 1997
33. VONESH EF, MORAN J: Mortality in end-stage renal disease: A reassessment of differences between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol 10:354-365, 1999
34. STACK AG: Determinants of modality choice among incident U.S. ESRD patients: A national study. J Am Soc Nephrol 13:1279-1287, 2002
35. FRIEDMAN EA: Selection bias impacts outcome reports of uremia therapy. Am J Kidney Dis 36:208-210, 2000
36. LONGENECKER JC, CORESH J, KLAG MJ, et al: Validation of comorbid conditions on the end-stage renal disease medical evidence report: The CHOICE study. Choices for Healthy Outcomes in Caring for ESRD. J Am Soc Nephrol 11:520-529, 2000
37. USRDS RENAL DATA SYSTEM: Comorbid conditions and correlations with mortality risk among 3,399 incident hemodialysis patients. Am J Kidney Dis 20:32-38, 1992